Avenue Therapeutics Inc is a specialty pharmaceutical company that develops and markets pharmaceutical products for the acute care setting. It focuses on developing its product candidate, an intravenous (IV) formulation of tramadol HCI (IV Tramadol), for post-operative acute pain.
Earnings
see more| Q1 2021 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2021-05-10 | ||||||
| REV | |||||||
| Q4 2020 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.070 | -0.060 | 0.0100 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| ATXI | Avenue Therapeutics | -0.84% | 79.9M |
Avenue Therapeutics Company Questions & Answers
Q
How do I buy Avenue Therapeutics (ATXI) stock?
A
You can purchase shares of Avenue Therapeutics (NASDAQ: ATXI) through any online brokerage.
Q
Who are Avenue Therapeutics's (ATXI) main competitors?
A
There are no as such competitors for Avenue Therapeutics.
Q
What is the target price for Avenue Therapeutics?
A
The latest price target for Avenue Therapeutics (NASDAQ: ATXI) was reported by HC Wainwright & Co. on 2020-05-12. The analyst firm set a price target for 13.00 expecting ATXI to rise to within 12 months (a possible 172.54% upside). 1 analyst firms have reported ratings in the last year.
Q
How much is Avenue Therapeutics (ATXI) stock ?
A
The stock price for Avenue Therapeutics (NASDAQ: ATXI) is $4.77 last updated Today at 8:00:02 PM.
Q
When is the next Avenue Therapeutics (ATXI) dividend?
A
There are no upcoming dividends for Avenue Therapeutics.
Q
When is Avenue Therapeutics (NASDAQ:ATXI) reporting earnings?
A
Avenue Therapeutics’s Q1 earnings are confirmed from now on May 10, 2021.
Q
When is the upcoming split for ATXI?
A
There is no upcoming split for Avenue Therapeutics.